NVIDIA GTC Conference 2024 Presentation Announcement
A closer look at ArtiDock and BioNeMo integration
NVIDIA GTC Conference 2024 Presentation Announcement
A closer look at ArtiDock and BioNeMo integration
PARTNERSHIP
Announcement
Summary
Receptor.AI CEO Dr. Alan Nafiiev will speak at the NVIDIA GTC Conference, presenting “Advancing Drug Design With Generative AI: An Integrated Workflow Using BioNeMo” on March 21 at 1:00 p.m. CET. The session will highlight the latest advancements in ArtiDock and its integration with NVIDIA’s BioNeMo platform. The event, held both in San Jose and online from March 18–21, features over 900 sessions covering AI, HPC, and more.
Full Text
We are happy to announce that our CEO, Dr. Alan Nafiiev, will be taking the stage at the NVIDIA GTC Conference – the premier event for the latest developments in AI technology!
Alan’s presentation, “Advancing Drug Design With Generative AI: An Integrated Workflow Using BioNeMo,” is scheduled for virtual attendance on March 21 at 1:00 p.m. CET.
This is your chance to get a firsthand look at the newest advancements of our AI docking model, ArtiDock, and its seamless integration with NVIDIA’s BioNeMo platform.
The conference, happening live in downtown San Jose and virtually from March 18-21, will feature over 900 sessions on everything from AI fundamentals to the latest research in HPC, cloud, and the metaverse, led by experts from around the globe.
Register now to participate virtually for free at NVIDIA GTC Conference.
Learn more details about BioNeMo integration on NVIDIA's blog and refer to Receptor.AI's case studies.
Learn more about ArtiDock's BioNeMo integration on NVIDIA's blog
